Dennis Raglin is a member of Rimon’s Litigation practice where he specializes in defending clients in the areas of products liability, including medical device and pharmaceutical, and in all types of general and complex litigation. He also counsels and defends clients in California’s Proposition 65 right-to-know chemical warnings law and green chemistry regulations in California and nationwide. Mr. Raglin has over twenty years of extensive litigation experience and has tried cases to verdict, including to defense verdict, and has achieved dismissals and summary judgments, as well as favorable settlements in mediation and arbitration, for a diverse group of clients. In his Proposition 65 and green chemistry practice, in addition to defending clients who have received notices of violation or are involved in litigation, Mr. Raglin advises companies large and small before litigation on minimizing their risk and employing best practices to ensure compliance with these often complicated laws.
Mr. Raglin’s wealth of experience has seen him represent a wide variety of clients in the fields of: medical device and pharmaceutical (both over-the-counter and prescription regulated by the FDA); automobiles; heavy equipment and power tools; food and dietary supplements; apparel and footwear; sporting goods; home furnishings; and cosmetics and personal care. He has also defended numerous clients in all types of litigation, including: personal injury cases involving catastrophic injuries and death; premises liability; contract disputes; and government entities sued for statutory violations. His clients have included Fortune 500 and international corporations, insurance carriers, wineries, retail establishments, government agencies, and small emerging companies. Regardless of the client, Mr. Raglin’s philosophy is to first understand it and its business, and to listen to what the client’s needs and goals are for the litigation at the outset – and then he works continuously throughout the course of his representation to effectively and efficiently achieve those goals to get the best result for the client.
Mr. Raglin has been both a speaker and an author of numerous articles in his fields of practice. In the area of Proposition 65 and green chemistry, he has authored several articles on aspects of these regulations and he regularly prepares “alerts” to keep firm clients apprised of proposed changes in the law and explain how they impact business. He has written and been a speaker in the areas of products liability, including analyzing compliance with FDA regulations governing medical device and pharmaceutical companies and evaluating products liability theories in expected future litigation against companies related to climate change. He has also been a repeat speaker regarding aspects of FDA-related rules and best practice for life science companies at CBI’s “Medical Communications and Information Summit.” His articles have been featured in a variety of national and state publications, including Bloomberg, Food and Safety Magazine and The San Francisco Daily Journal.
Prior to joining Rimon, Mr. Raglin was a partner at Sedgwick LLP in San Francisco where he was a member of the Life Science practice group and chaired the firm’s Proposition 65 and Green Chemistry practice group.
